Health care industry dash out into medical innovation to novel treatment that remains unmatched to several vulnerable populations.
The ethical and economic challenges related to policy decision were discussed at length in the Washington post article (Sein, 2010). The major concern is ethical and cost-effectiveness related to life extension. American health care cost is the most expensive worldwide, and to add Provenge cost into Medicare will impose a hike in tax to many citizens. According to Stein (2010), the cancer drug Provenge cost $93,000 per patient with life extension of four months, which is extremely expensive. The life extension cost of the prostate cancer drug Provenge has both ethical and economic implication. …show more content…
Even though it unethical for the cost to prevent care, several stakeholders were against care due to economic reasons. It is also unethical for government health policy namely Medicare and Medicaid to rank ailment at the sacrifice of another. The government has an obligation to cover the Medicare and Medicaid qualified participant health issues (Milstead, 2013). Ethically, every patient has right to be treated equally and equitably in